BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 27733687)

  • 1. Enhanced Cytosolic Ca2+ Activation Underlies a Common Defect of Central Domain Cardiac Ryanodine Receptor Mutations Linked to Arrhythmias.
    Xiao Z; Guo W; Sun B; Hunt DJ; Wei J; Liu Y; Wang Y; Wang R; Jones PP; Back TG; Chen SRW
    J Biol Chem; 2016 Nov; 291(47):24528-24537. PubMed ID: 27733687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extensive Ca2+ leak through K4750Q cardiac ryanodine receptors caused by cytosolic and luminal Ca2+ hypersensitivity.
    Uehara A; Murayama T; Yasukochi M; Fill M; Horie M; Okamoto T; Matsuura Y; Uehara K; Fujimoto T; Sakurai T; Kurebayashi N
    J Gen Physiol; 2017 Feb; 149(2):199-218. PubMed ID: 28082361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The EF-hand Ca2+ Binding Domain Is Not Required for Cytosolic Ca2+ Activation of the Cardiac Ryanodine Receptor.
    Guo W; Sun B; Xiao Z; Liu Y; Wang Y; Zhang L; Wang R; Chen SR
    J Biol Chem; 2016 Jan; 291(5):2150-60. PubMed ID: 26663082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced threshold for store overload-induced Ca
    Chen W; Koop A; Liu Y; Guo W; Wei J; Wang R; MacLennan DH; Dirksen RT; Chen SRW
    Biochem J; 2017 Aug; 474(16):2749-2761. PubMed ID: 28687594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Arrhythmogenic Calmodulin p.Phe142Leu Mutation Impairs C-domain Ca2+ Binding but Not Calmodulin-dependent Inhibition of the Cardiac Ryanodine Receptor.
    Søndergaard MT; Liu Y; Larsen KT; Nani A; Tian X; Holt C; Wang R; Wimmer R; Van Petegem F; Fill M; Chen SR; Overgaard MT
    J Biol Chem; 2017 Jan; 292(4):1385-1395. PubMed ID: 27927985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arrhythmogenic Calmodulin Mutations Affect the Activation and Termination of Cardiac Ryanodine Receptor-mediated Ca2+ Release.
    Søndergaard MT; Tian X; Liu Y; Wang R; Chazin WJ; Chen SR; Overgaard MT
    J Biol Chem; 2015 Oct; 290(43):26151-62. PubMed ID: 26309258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Cytoplasmic Region of Inner Helix S6 Is an Important Determinant of Cardiac Ryanodine Receptor Channel Gating.
    Sun B; Guo W; Tian X; Yao J; Zhang L; Wang R; Chen SR
    J Biol Chem; 2016 Dec; 291(50):26024-26034. PubMed ID: 27789712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The central domain of cardiac ryanodine receptor governs channel activation, regulation, and stability.
    Guo W; Sun B; Estillore JP; Wang R; Chen SRW
    J Biol Chem; 2020 Nov; 295(46):15622-15635. PubMed ID: 32878990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The H29D Mutation Does Not Enhance Cytosolic Ca2+ Activation of the Cardiac Ryanodine Receptor.
    Xiao Z; Guo W; Yuen SM; Wang R; Zhang L; Van Petegem F; Chen SR
    PLoS One; 2015; 10(9):e0139058. PubMed ID: 26405799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium leak through ryanodine receptors leads to atrial fibrillation in 3 mouse models of catecholaminergic polymorphic ventricular tachycardia.
    Shan J; Xie W; Betzenhauser M; Reiken S; Chen BX; Wronska A; Marks AR
    Circ Res; 2012 Aug; 111(6):708-17. PubMed ID: 22828895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nebivolol suppresses cardiac ryanodine receptor-mediated spontaneous Ca2+ release and catecholaminergic polymorphic ventricular tachycardia.
    Tan Z; Xiao Z; Wei J; Zhang J; Zhou Q; Smith CD; Nani A; Wu G; Song LS; Back TG; Fill M; Chen SR
    Biochem J; 2016 Nov; 473(22):4159-4172. PubMed ID: 27623776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-β-blocking R-carvedilol enantiomer suppresses Ca2+ waves and stress-induced ventricular tachyarrhythmia without lowering heart rate or blood pressure.
    Zhang J; Zhou Q; Smith CD; Chen H; Tan Z; Chen B; Nani A; Wu G; Song LS; Fill M; Back TG; Chen SR
    Biochem J; 2015 Sep; 470(2):233-42. PubMed ID: 26348911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A gain of function ryanodine receptor 2 mutation (R1760W-RyR2) in catecholaminergic polymorphic ventricular tachycardia.
    Li S; Lv T; Yang J; Li K; Yang Y; Zhang P
    Clin Exp Pharmacol Physiol; 2023 Jan; 50(1):39-49. PubMed ID: 36082968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of loss-of-function RyR2 mutations associated with idiopathic ventricular fibrillation and sudden death.
    Zhong X; Guo W; Wei J; Tang Y; Liu Y; Zhang JZ; Tan VH; Zhang L; Wang R; Jones PP; Napolitano C; Priori SG; Chen SRW
    Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33825858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of ryanodine receptor function prolongs Ca2+ release refractoriness and promotes cardiac alternans in intact hearts.
    Zhong X; Sun B; Vallmitjana A; Mi T; Guo W; Ni M; Wang R; Guo A; Duff HJ; Gillis AM; Song LS; Hove-Madsen L; Benitez R; Chen SR
    Biochem J; 2016 Nov; 473(21):3951-3964. PubMed ID: 27582498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cardiac ryanodine receptor, but not sarcoplasmic reticulum Ca
    Sun B; Wei J; Zhong X; Guo W; Yao J; Wang R; Vallmitjana A; Benitez R; Hove-Madsen L; Chen SRW
    J Biol Chem; 2018 Aug; 293(35):13650-13661. PubMed ID: 29986885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CPVT-associated cardiac ryanodine receptor mutation G357S with reduced penetrance impairs Ca2+ release termination and diminishes protein expression.
    Liu Y; Wei J; Wong King Yuen SM; Sun B; Tang Y; Wang R; Van Petegem F; Chen SRW
    PLoS One; 2017; 12(9):e0184177. PubMed ID: 28961276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Divergent regulation of ryanodine receptor 2 calcium release channels by arrhythmogenic human calmodulin missense mutants.
    Hwang HS; Nitu FR; Yang Y; Walweel K; Pereira L; Johnson CN; Faggioni M; Chazin WJ; Laver D; George AL; Cornea RL; Bers DM; Knollmann BC
    Circ Res; 2014 Mar; 114(7):1114-24. PubMed ID: 24563457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Na+-dependent SR Ca2+ overload induces arrhythmogenic events in mouse cardiomyocytes with a human CPVT mutation.
    Sedej S; Heinzel FR; Walther S; Dybkova N; Wakula P; Groborz J; Gronau P; Maier LS; Vos MA; Lai FA; Napolitano C; Priori SG; Kockskämper J; Pieske B
    Cardiovasc Res; 2010 Jul; 87(1):50-9. PubMed ID: 20080988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RyR2 disease mutations at the C-terminal domain intersubunit interface alter closed-state stability and channel activation.
    Guo W; Wei J; Estillore JP; Zhang L; Wang R; Sun B; Chen SRW
    J Biol Chem; 2021 Jul; 297(1):100808. PubMed ID: 34022226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.